Asthma Control and Sputum Eosinophils: A Longitudinal Study in Daily Practice

被引:47
作者
Demarche, Sophie F. [1 ,2 ]
Schleich, Florence N. [1 ]
Paulus, Virginie A. [1 ]
Henket, Monique A. [1 ]
Van Hees, Thierry J. [2 ]
Louis, Renaud E. [1 ]
机构
[1] Univ Liege, GIGA Res Grp I3, Dept Resp Med, Liege, Belgium
[2] Univ Liege, Ctr Interdisciplinary Res Med, Dept Clin Pharm, Liege, Belgium
关键词
Asthma control; Sputum eosinophils; Longitudinal study; Daily practice; AIRWAY INFLAMMATION; CXCR2; ANTAGONIST; PREDICT; EXACERBATIONS; QUESTIONNAIRE; SUBGROUP; EFFICACY; COUNTS; TRIALS; SAFETY;
D O I
10.1016/j.jaip.2017.01.026
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BACKGROUND: Longitudinal trials have suggested that asthma control may be influenced by fluctuations in eosinophilic inflammation. This association has however never been confirmed in daily practice. OBJECTIVE: To investigate the relationship between asthma control and sputum eosinophils in clinical practice. METHODS: A retrospective longitudinal study was conducted on 187 patients with asthma with at least 2 successful sputum inductions at our Asthma Clinic. Linear mixed models were used to assess the relationship between asthma control and individual changes in sputum eosinophils. Receiver-operating characteristic curves were constructed to define minimal important differences (MIDs) of sputum eosinophils associated with a change of at least 0.5 in Asthma Control Questionnaire (ACQ) score. Then, a validation cohort of 79 patients with asthma was recruited to reassess this relationship and the accuracy of the MID values. RESULTS: A multivariate analysis showed that asthma control was independently associated with individual fluctuations in sputum eosinophil count (P < .001). In patients with intermittent/persistently eosinophilic asthma, we calculated a minimal important decrease of 4.3% in the percentage of sputum eosinophils (area under the curve [AUC], 0.69; P < .001) or 3.4-fold (AUC, 0.65; P = .003) for a significant improvement in asthma control and a minimal important increase of 3.5% (AUC, 0.67; P = .004) or 1.8-fold (AUC, 0.63; P = .02) for a significant worsening in asthma control. The association between asthma control and sputum eosinophils and the accuracy of the MIDs of sputum eosinophils were confirmed in the validation cohort. CONCLUSIONS: At the individual level, asthma control was associated with fluctuations in sputum eosinophil count over time. (C) 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
引用
收藏
页码:1335 / +
页数:14
相关论文
共 44 条
[1]   Understanding diagnostic tests 3: receiver operating characteristic curves [J].
Akobeng, Anthony K. .
ACTA PAEDIATRICA, 2007, 96 (05) :644-647
[2]   Severe adult-onset asthma: A distinct phenotype [J].
Amelink, Marijke ;
de Groot, Jantina C. ;
de Nijs, Selma B. ;
Lutter, Rene ;
Zwinderman, Aeilko H. ;
Sterk, Peter J. ;
ten Brinke, Anneke ;
Bel, Elisabeth H. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (02) :336-341
[3]   Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients [J].
Bacci, E ;
Cianchetti, S ;
Bartoli, M ;
Dente, FL ;
Di Franco, A ;
Vagagaini, B ;
Paggiaro, P .
CHEST, 2006, 129 (03) :565-572
[4]   The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement [J].
Benchimol, Eric I. ;
Smeeth, Liam ;
Guttmann, Astrid ;
Harron, Katie ;
Moher, David ;
Petersen, Irene ;
Sorensen, Henrik T. ;
von Elm, Erik ;
Langan, Sinead M. .
PLOS MEDICINE, 2015, 12 (10)
[5]   Reslizumab for Poorly Controlled, Eosinophilic Asthma A Randomized, Placebo-controlled Study [J].
Castro, Mario ;
Mathur, Sameer ;
Hargreave, Frederick ;
Boulet, Louis-Philippe ;
Xie, Fang ;
Young, James ;
Wilkins, H. Jeffrey ;
Henkel, Timothy ;
Nair, Parameswaran .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (10) :1125-1132
[6]   A comparison of medication adherence/persistence for asthma and chronic obstructive pulmonary disease in the United Kingdom [J].
Covvey, J. R. ;
Mullen, A. B. ;
Ryan, M. ;
Steinke, D. T. ;
Johnston, B. F. ;
Wood, F. T. ;
Boyter, A. C. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (10) :1200-1208
[7]   Biomarker-based asthma phenotypes of corticosteroid response [J].
Cowan, Douglas C. ;
Taylor, D. Robin ;
Peterson, Laura E. ;
Cowan, Jan O. ;
Palmay, Rochelle ;
Williamson, Avis ;
Hammel, Jef ;
Erzurum, Serpil C. ;
Hazen, Stanley L. ;
Comhair, Suzy A. A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (04) :877-+
[8]   Effects of steroid therapy on inflammatory cell subtypes in asthma [J].
Cowan, Douglas C. ;
Cowan, Jan O. ;
Palmay, Rochelle ;
Williamson, Avis ;
Taylor, D. Robin .
THORAX, 2010, 65 (05) :384-390
[9]   Sample sizes for clinical trials using sputum eosinophils as a primary outcome [J].
Dasgupta, Angira ;
Zhang, Shiyuan ;
Thabane, Lehana ;
Nair, Parameswaran .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (04) :1003-1011
[10]   Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma [J].
Delvaux, M ;
Henket, M ;
Lau, L ;
Kange, P ;
Bartsch, P ;
Djukanovic, R ;
Louis, R .
THORAX, 2004, 59 (02) :111-115